The American Hospital Association has lauded efforts by the Centers for Medicare and Medicaid Services to limit short-term “junk” health plans, but is pressing the agency to do more on the issue of unaffordable cost sharing, “even in ACA compliant health plans,” the AHA wrote in a letter to CMS this week.

More than three quarters (78%) of respondents to a new Claroty survey  experienced a minimum   of one cybersecurity incident over the last year, which impacted a broad range of asset types, including IT systems, sensitive data, medical devices and building management systems.

Mytonomy offers patient education and has expanded its offerings to move patients smoothly through pre- and post-procedure functions, says CEO and cofounder Anjali Kataria.

In assessing the biggest risks to their business, most healthcare executives say that the risk landscape is starting to ease, with recessionary fears not as prevalent as they once were and the overall picture improving for talent acquisition and retention – although cyberattacks and uneven economic growth remain top concerns.

The Texas Medical Association has once again prevailed in a legal challenge to President Biden’s No Surprises Act, with a Texas judge ruling to vacate several regulations involving payment dispute resolutions between some out-of-network providers, group health plans and payers. It’s the fourth successful legal challenge TMA has made against the NSA, which bans surprise […]

A new partnership between Humana and kidney care management company Interwell Health will result in a new value-based care agreement in 13 states for most Humana Medicare Advantage HMO and PPO members living with chronic kidney disease (CKD), as well as members across the country living with end-stage kidney disease (ESKD).

Staff members need flexibility, new challenges and time to be creative to aspire to go further in their careers, says Dr. Shafi Ahmed, CMO of Medical Realities.  

The Centers for Medicare and Medicaid Services has released the names of 10 drugs that will be subject to federal price negotiation in the Medicare program.  The selected drug list for the first round of negotiation is:

Americans are largely on board with the concept of value-based care, but there’s one thing they don’t seem to like that much: the term itself, which they either don’t resonate with or don’t understand. That’s according to new research from United States of Care, which found that 64% of the 1,000 people surveyed preferred value-based […]

With the expiration of the public health emergency ending waivers and flexibilities, providers are looking for answers, says Dr. Robert Murry, chief medical officer of NextGen Healthcare.